Ivermectin effectively inhibits hepatitis E virus replication, requiring the host nuclear transport protein importin α1

被引:0
|
作者
Yunlong Li
Zhijiang Miao
Pengfei Li
Ruyi Zhang
Denis E. Kainov
Zhongren Ma
Robert A. de Man
Maikel P. Peppelenbosch
Qiuwei Pan
机构
[1] Erasmus MC-University Medical Center,Department of Gastroenterology and Hepatology
[2] Norwegian University of Science and Technology,Department of Clinical and Molecular Medicine
[3] University of Tartu,Institute of Technology
[4] Northwest Minzu University,Biomedical Research Center
来源
Archives of Virology | 2021年 / 166卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
We show that ivermectin, an FDA-approved anti-parasitic drug, effectively inhibits infection with hepatitis E virus (HEV) genotypes 1 and 3 in a range of cell culture models, including hepatic and extrahepatic cells. Long-term treatment showed no clear evidence of the development of drug resistance. Gene silencing of importin-α1, a cellular target of ivermectin and a key member of the host nuclear transport complex, inhibited viral replication and largely abolished the anti-HEV effect of ivermectin.
引用
收藏
页码:2005 / 2010
页数:5
相关论文
共 50 条
  • [1] Ivermectin effectively inhibits hepatitis E virus replication, requiring the host nuclear transport protein importin α1
    Li, Yunlong
    Miao, Zhijiang
    Li, Pengfei
    Zhang, Ruyi
    Kainov, Denis E.
    Ma, Zhongren
    de Man, Robert A.
    Peppelenbosch, Maikel P.
    Pan, Qiuwei
    [J]. ARCHIVES OF VIROLOGY, 2021, 166 (07) : 2005 - 2010
  • [2] Granzyme K inhibits replication of influenza virus through cleaving the nuclear transport complex importin α1/β dimer of infected host cells
    Zhong, C.
    Li, C.
    Wang, X.
    Toyoda, T.
    Gao, G.
    Fan, Z.
    [J]. CELL DEATH AND DIFFERENTIATION, 2012, 19 (05): : 882 - 890
  • [3] Granzyme K inhibits replication of influenza virus through cleaving the nuclear transport complex importin α1/β dimer of infected host cells
    C Zhong
    C Li
    X Wang
    T Toyoda
    G Gao
    Z Fan
    [J]. Cell Death & Differentiation, 2012, 19 : 882 - 890
  • [4] The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer
    Yang, Sundy N. Y.
    Atkinson, Sarah C.
    Wang, Chunxiao
    Lee, Alexander
    Bogoyevitch, Marie A.
    Borg, Natalie A.
    Jans, David A.
    [J]. ANTIVIRAL RESEARCH, 2020, 177
  • [5] Inhibition of Human Adenovirus Replication by the Importin α/β1 Nuclear Import Inhibitor Ivermectin
    King, Cason R.
    Tessier, Tanner M.
    Dodge, Mackenzie J.
    Weinberg, Jason B.
    Mymryk, Joe S.
    [J]. JOURNAL OF VIROLOGY, 2020, 94 (18)
  • [6] Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
    Wagstaff, Kylie M.
    Sivakumaran, Haran
    Heaton, Steven M.
    Harrich, David
    Jans, David A.
    [J]. BIOCHEMICAL JOURNAL, 2012, 443 : 851 - 856
  • [7] Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication
    Srinivas, RV
    Ray, RB
    Meyer, K
    Ray, R
    [J]. VIRUS RESEARCH, 1996, 45 (02) : 87 - 92
  • [8] Full-length MAVS, a mitochondrial antiviral-signaling protein, inhibits hepatitis E virus replication, requiring JAK-STAT signaling
    Qu, Changbo
    Li, Yang
    Li, Yunlong
    Pan, Yihang
    [J]. ARCHIVES OF VIROLOGY, 2022, 167 (05) : 1293 - 1300
  • [9] Full-length MAVS, a mitochondrial antiviral-signaling protein, inhibits hepatitis E virus replication, requiring JAK-STAT signaling
    Changbo Qu
    Yang Li
    Yunlong Li
    Yihang Pan
    [J]. Archives of Virology, 2022, 167 : 1293 - 1300
  • [10] Novel Flavivirus Antiviral That Targets the Host Nuclear Transport Importin α/β1 Heterodimer
    Yang, Sundy N. Y.
    Atkinson, Sarah C.
    Fraser, Johanna E.
    Wang, Chunxiao
    Maher, Belinda
    Roman, Noelia
    Forwood, Jade K.
    Wagstaff, Kylie M.
    Borg, Natalie A.
    Jans, David A.
    [J]. CELLS, 2019, 8 (03)